20-F/A

AMENDMENT NO. 1

Company: NYMOX PHARMACEUTICAL CORP
Filed: October 24, 2005
Period of Report: December 31, 2004
Accession Number: 0000897069-05-002569

View Document ↗ View on SEC.gov ↗